Profile | GDS4284 / 202773_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 891.713 | 73 |
GSM687648 | Patient 402 control | 964.533 | 73 |
GSM687653 | Patient 403 control | 1190.97 | 77 |
GSM687658 | Patient 404 control | 992.146 | 74 |
GSM687663 | Patient 411 control | 1341.32 | 78 |
GSM687668 | Patient 422 control | 1469.33 | 80 |
GSM687673 | Patient 424 control | 1191.16 | 76 |
GSM687678 | Patient 425 control | 1250.08 | 77 |
GSM687683 | Patient 427 control | 1077.55 | 75 |
GSM687688 | Patient 428 control | 983.054 | 74 |
GSM687695 | Patient 441 control | 449.094 | 59 |
GSM687699 | Patient 443 control | 497.498 | 62 |
GSM687704 | Patient 444 control | 1055.74 | 75 |
GSM687707 | Patient 448 control | 1283.18 | 78 |
GSM687712 | Patient 449 control | 783.571 | 70 |
GSM687719 | Patient 450 control | 928.098 | 72 |
GSM687724 | Patient 451 control | 957.912 | 74 |
GSM687728 | Patient 452 control | 703.411 | 69 |
GSM687646 | Patient 401 treated 24h | 1251.49 | 77 |
GSM687649 | Patient 402 treated 24h | 1202.5 | 76 |
GSM687665 | Patient 411 treated 24h | 1193.19 | 77 |
GSM687651 | Patient 402 treated 4 weeks | 1593.87 | 81 |
GSM687667 | Patient 411 treated 4 weeks | 1342.04 | 78 |
GSM687670 | Patient 422 treated 24h | 1601.02 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1923.07 | 83 |
GSM687654 | Patient 403 treated 24h | 1153.88 | 76 |
GSM687675 | Patient 424 treated 24h | 1031.76 | 74 |
GSM687685 | Patient 427 treated 24h | 1404.88 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 1289.01 | 78 |
GSM687677 | Patient 424 treated 4 weeks | 1173.1 | 76 |
GSM687687 | Patient 427 treated 4 weeks | 1633.04 | 81 |
GSM687692 | Patient 428 treated 4h | 380.064 | 59 |
GSM687716 | Patient 449 treated 4h | 669.213 | 68 |
GSM687722 | Patient 450 treated 4h | 336.257 | 56 |
GSM687680 | Patient 425 treated 24h | 1068.24 | 75 |
GSM687690 | Patient 428 treated 24h | 294.051 | 56 |
GSM687700 | Patient 443 treated 24h | 617.509 | 65 |
GSM687705 | Patient 444 treated 24h | 1100.19 | 76 |
GSM687714 | Patient 449 treated 24h | 861.804 | 72 |
GSM687721 | Patient 450 treated 24h | 611.526 | 66 |
GSM687682 | Patient 425 treated 4 weeks | 872.796 | 72 |
GSM687694 | Patient 428 treated 4 weeks | 686.377 | 68 |
GSM687702 | Patient 443 treated 4 weeks | 743.795 | 69 |
GSM687718 | Patient 449 treated 4 weeks | 667.848 | 68 |
GSM687723 | Patient 450 treated 4 weeks | 489.881 | 63 |
GSM687661 | Patient 404 treated 4h | 956.653 | 73 |
GSM687710 | Patient 448 treated 4h | 1392.01 | 79 |
GSM687726 | Patient 451 treated 4h | 1252.81 | 77 |
GSM687730 | Patient 452 treated 4h | 357.499 | 46 |
GSM687660 | Patient 404 treated 24h | 289.836 | 53 |
GSM687697 | Patient 441 treated 24h | 585.917 | 65 |
GSM687709 | Patient 448 treated 24h | 1206.76 | 77 |
GSM687725 | Patient 451 treated 24h | 1198.76 | 77 |
GSM687729 | Patient 452 treated 24h | 843.651 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 1505.9 | 80 |
GSM687731 | Patient 452 treated 4 weeks | 1197.23 | 77 |